121 related articles for article (PubMed ID: 3093412)
1. Immunogenetic profile of multiple sclerosis in Mexicans.
Gorodezky C; Najera R; Rangel BE; Castro LE; Flores J; Velázquez G; Granados J; Sotelo J
Hum Immunol; 1986 Aug; 16(4):364-74. PubMed ID: 3093412
[TBL] [Abstract][Full Text] [Related]
2. HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis.
Alvarado-de la Barrera C; Zúñiga-Ramos J; Ruíz-Morales JA; Estañol B; Granados J; Llorente L
Neurology; 2000 Dec; 55(12):1897-900. PubMed ID: 11134391
[TBL] [Abstract][Full Text] [Related]
3. HLA and multiple sclerosis: population and families study.
Govaerts A; Gony J; Martin-Mondiére C; Poirier JC; Schmid M; Schuller E; Degos JD; Dausset J
Tissue Antigens; 1985 Apr; 25(4):187-99. PubMed ID: 3874450
[TBL] [Abstract][Full Text] [Related]
4. [Complement markers Bf and C4 in multiple sclerosis].
Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
[TBL] [Abstract][Full Text] [Related]
5. HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells.
Brautbar C; Amar A; Cohen N; Oksenberg J; Cohen I; Kahana E; Bloch D; Alter M; Grosse-Wilde H
Tissue Antigens; 1982 Mar; 19(3):189-97. PubMed ID: 6953617
[TBL] [Abstract][Full Text] [Related]
6. Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis.
Gyódi E; Benczur M; Pálffy G; Tálas M; Petrányi G; Földes I; Hollán SR
Hum Immunol; 1982 Jun; 4(3):209-17. PubMed ID: 6181031
[TBL] [Abstract][Full Text] [Related]
7. HLA profiles in multiple sclerosis suggest two forms of disease and the existence of protective haplotypes.
Madigand M; Oger JJ; Fauchet R; Sabouraud O; Genetet B
J Neurol Sci; 1982 Mar; 53(3):519-29. PubMed ID: 6978384
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis in north-east Scotland. An association with HLA-DQw1.
Francis DA; Batchelor JR; McDonald WI; Hing SN; Dodi IA; Fielder AH; Hern JE; Downie AW
Brain; 1987 Feb; 110 ( Pt 1)():181-96. PubMed ID: 3492235
[TBL] [Abstract][Full Text] [Related]
9. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
[TBL] [Abstract][Full Text] [Related]
10. Virus-specific cytotoxic T cells in multiple sclerosis.
McFarland HF; Goodman A; Jacobson S
Ann N Y Acad Sci; 1988; 532():273-9. PubMed ID: 3263072
[No Abstract] [Full Text] [Related]
11. Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics.
Matsuki K; Juji T; Tokunaga K; Naohara T; Satake M; Honda Y
J Clin Invest; 1985 Dec; 76(6):2078-83. PubMed ID: 3865934
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR-dependent variation of intrathecal IgG1 (Gm) allotype synthesis in multiple sclerosis.
Salier JP; Martin-Mondiere C; Sesboüé R; Daveau M; Goust JM; Govaerts A; Schuller E; Degos JD
J Immunol; 1985 Mar; 134(3):1551-4. PubMed ID: 3855432
[TBL] [Abstract][Full Text] [Related]
13. HLA associations with multiple sclerosis in Sicily and Malta.
Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
[TBL] [Abstract][Full Text] [Related]
14. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
[TBL] [Abstract][Full Text] [Related]
15. Association of HLA and multiple sclerosis.
Martin R; Vogt AB; Kropshofer H; Lichtenfels R
Behring Inst Mitt; 1994 Jul; (94):158-70. PubMed ID: 7998908
[TBL] [Abstract][Full Text] [Related]
16. HLA antigens in multiple sclerosis in coloured South Africans.
Fewster ME; Kies B
J Neurol Sci; 1984; 66(2-3):175-81. PubMed ID: 6597862
[TBL] [Abstract][Full Text] [Related]
17. [11th International Histocompatibility Workshop 1991: Personal data for the Multiple Sclerosis Study].
Wegener S; Falk U; Lakner K; Meyer-Riennecker HJ; Hauptmann G; Uring-Lambert B
Beitr Infusionsther; 1992; 30():324-31. PubMed ID: 1284726
[TBL] [Abstract][Full Text] [Related]
18. A functional basis for the association of HLA class II genes and susceptibility to multiple sclerosis: cellular immune responses to myelin basic protein in a multiplex family.
Voskuhl RR; Martin R; McFarland HF
J Neuroimmunol; 1993 Feb; 42(2):199-207. PubMed ID: 7679119
[TBL] [Abstract][Full Text] [Related]
19. HLA antigens and progression of multiple sclerosis. Part II.
Dejaegher L; de Bruyere M; Ketelaer P; Carton H
J Neurol; 1983; 229(3):167-74. PubMed ID: 6191008
[TBL] [Abstract][Full Text] [Related]
20. HLA, blood groups and secretor status in patients with established rheumatic fever and rheumatic heart disease.
Jhinghan B; Mehra NK; Reddy KS; Taneja V; Vaidya MC; Bhatia ML
Tissue Antigens; 1986 Mar; 27(3):172-8. PubMed ID: 3087020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
